Ezetimibe and low density lipoprotein subfractions: an ongoing debate

By Katsiki Niki   Athyros Vasilis G.   Karagiannis Asterios   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 693-695

Informa Healthcare

Access to resources Recommend Favorite

The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterolemia

By Florentin Matilda   Liberopoulos Evangelos N.   Moutzouri Elisavet   Rizos Christos V.   Tselepis Alexandros D.   Elisaf Moses S.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 685-692

Informa Healthcare

Access to resources Recommend Favorite

Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe)

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 371-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin

By Gazi Irene F.   Daskalopoulou Stella S.   Nair Devaki R.   Mikhailidis Dimitri P.  

Current Medical Research and Opinion, Vol. 23, Iss. 9, 2007-09 ,pp. : 2183-2192

Informa Healthcare

Access to resources Recommend Favorite

Total and low-density lipoprotein cholesterol in high-risk patients treated with atorvastatin monotherapy in the United Kingdom: analysis of a primary-care database

By Jameson Kevin   Zhang Qiaoyi   Zhao Changgeng   Ramey Dena Rosen   Tershakovec Andrew M.   Gutkin Stephen W.   Marrett Elizabeth  

Current Medical Research and Opinion, Vol. 30, Iss. 4, 2014-04 ,pp. : 655-665

Informa Healthcare

Access to resources Recommend Favorite